跳至主要内容
临床试验/ACTRN12614000004662
ACTRN12614000004662已完成2 期

In adult patients with rosacea will topical medical grade Kanuka honey reduce rosacea severity compared with Cetomacrogol control cream.

Honeylab Ltd0 个研究点目标入组 138 人开始时间: 2014年1月2日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
138

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Aged 16 or over at the time of enrolment
  • Baseline facial Rosacea Severity Score (RSS) of 2 or greater

排除标准

  • Requirement for systemic corticosteroids, or systemic corticosteroid treatment in the 4 weeks prior to Visit 1 Current requirement for oral or topical antibiotic therapy for rosacea Current requirement for topical corticosteroid treatment for rosacea Known or suspected allergy to honey, or Cetomacrogol control cream Any other condition which, at the investigator's discretion, it is believed may present a safety risk or impact the feasibility of the study or the study results

研究者

发起方
Honeylab Ltd

相似试验